MDMA-assisted therapy and current treatment options for chronic, treatment-resistant, moderate or higher severity post-traumatic stress disorder: Systematic literature review.

PLoS One · 2025 · PMC12266454 · PMID 40668854

Europe PMC DOI

hedged sentence

0.6830

closest p · 13.7× alpha

0.6830

boldest claim

The sentences

failed to reach significancep = 0.683not close (p > 0.1)

However, venlafaxine ER failed to reach significance in SDS score change compared to sertraline after 12 weeks (8.5 vs. 8.2 points decrease, respectively; p = 0.683) [ 59 , 74 ].

also in 4,113 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.